Enter your login e-mail to the account
Search
- Myelosuppression in patients undergoing anticancer treatment of nonhematologic malignancies
MUDr. Soňa Huľová, PhD.
(4/2025, Interdisciplinary consilium ) - Early detection of hematological malignancies in the general practitioner’s office
MUDr. Kinga Dedinská, PhD.
(3-4/2026, Interdisciplinary consilium ) - Spolupráca praktického lekára a onkológa v liečení onkologického pacienta
MUDr. Miriam Ladická
(3/2006, Consilium ) - Current recommendations for the treatment of growth factors granulocytopoiesis
MUDr. Michal Chovanec
(6/2013, Interdisciplinary consilium ) - HIGH VIROLOGIC SUSTAINED RESPONSE TO FORMER YOUNG INTRAVENOUS DRUG ABUSERS WITH CHRONIC HEPATITIS C TREATED BY PEGYlATED INTERFERON – ALFA PLUS RIBAVIRIN (PRELIMINARY REPORT)
doc. MUDr. František Gazdík, doc. MUDr. Dušan Daniš CSc., RNDr. Kristína Fejdiová, MUDr. Michal Rastislav Piják, MUDr. Alexandra Mesárošová, MUDr. Ľubomír Okruhlica,, MUDr. Karol Laktiš, CSc., MUDr. Igor Stankovič, CSc., doc. MUDr. Katarína Gazdíková, PhD.
(10/2006, From practice ) - PRAKTICKÝ POHĽAD NA DIAGNOSTIKU A LIEČBU INFEKCIÍ ONKOLOGICKÝCH PACIENTOV
h. doc. MUDr. Ľuboš Drgoňa, CSc.
(S2/2007, Supplement ) - PULMONARY MYCOSES
h. doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Veronika Ballová, MUDr. Miriam Ladická, MUDr. Ján Lakota, CSc., MUDr. Andrej Vranovský, prof. RNDr. Jan Trupl, CSc.
(7-8/2005, clearly ) - Selected oncological emergencies review
MUDr. Soňa Huľová, PhD.
(6/2025, Interdisciplinary consilium ) - PERIODONTAL DISEASES
doc. MUDr. Dagmar Statelová, PhD.
(6/2007, clearly ) - Non-pharmacological therapy of patient with cancer
MUDr. Pavel Kotouček, FRCPath, prof. Robert Enright, PhD., doc. PhDr. Eva Naništová, CSc., RNDr. Ján Sedlák, DrSc.
(4/2021, Interdisciplinary consilium )
- Overlaps and differences between schizophrenia and bipolar disorder
MUDr. Dagmar Breznoščáková, MUDr. Jozef Dragašek, PhD.
(6/2009, Review articles ) - Aripiprazole in the treatment of bipolar disorder – its use in the clinical practice
MUDr. Sylva Racková, Ph.D.
(1/2017, Original articles & case reports ) - Reinitiation of clozapine treatment
MUDr. Michaela Mayerová, Ph.D., prof. MUDr. Libor Ustohal, Ph.D.
(4/2024, Review articles )
- Intravenous immunoglobulin therapy for autoimmune neurological disorders
doc. MUDr. Peter Špalek, PhD.
(6/2011, Main topic ) - Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective
Prof. MUDr. Tomáš Kozák, Ph.D.
(6/2016, From the boundary of neurology ) - INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR NEUROLOGIC DISORDERS: AN UPDATE AND PRACTICAL ISSUES
doc. MUDr. Peter Špalek, CSc.
(6/2008, Review articles )
- Komentár k článku: Neutropénia u detí – diagnostický a liečebný postup Pediatr. prax, 2020;21(4):165-170
Doc. MUDr. Vladimír Bzdúch, CSc.
(5/2020, Information & comments ) - Childhood acute leukemia
doc. MUDr. Emília Kaiserová, CSc., MUDr. Alexandra Kolenová, PhD.
(4/2012, Review articles ) - One morning, when Gregor Samsa woke from troubled dreams
MUDr. Veronika Vestenická, PhD.
(2/2017 ) - Mucormycosis as a life-threatening complication in patients with acute leukemia
MUDr. Eva Bačová, MUDr. Filip Chovanec, MUDr. Miroslava Makohusová, PhD., MUDr. Stanislava Hederová, MUDr. Martina Mikesková, MUDr. Andrea Hrašková, prof. MUDr. Bruno Rudinský, CSc., prof. MUDr. Lukáš Plank, CSc., Mgr. Pavlína Volfová, Ph.D., doc. MUDr. Alexandra Kolenová, PhD.
(1/2020, Original articles & Case reports ) - Prolonged fever and fever of unknown origin in children
prof. MUDr. László Kovács, DrSc., MPH
(1/2009, Review articles ) - Heart failure as initial manifestation of Barth syndrome
MUDr. Pavel Vít , MUDr. Michal Ryzí, MUDr. Marie Ryzí, MUDr. Miroslava Burešová, MUDr. Stella Mazurová
(6/2015, Electronic attachment ) - Deficiency of adenosine deaminase type 2 (DADA2): clinical picture, diagnosis and treatment
MUDr. Barbora Balažiová, MUDr. Gabriela Hrčková, MUDr. Veronika Dobšinská, Doc. MUDr. Tomáš Dallos, PhD.
(4/2024, Review articles ) - Neutropenia in children – diagnostic and treatment method
MUDr. Oksana Fábri, PhD.
(4/2020, Guidelines ) - Abstrakty prednášok Pracovná konferencia Detskej kliniky LF UK a NÚDCH – virtuálna konferencia – 1. časť
Kolektív autorov
(1/2021, Events ) - New intravenous cephalosporines in pediatrics: ceftaroline, and ceftazidime-avibactam
doc. MUDr. Ľubica Kováčiková, PhD.
(3/2022, Review articles )
- Sacituzumab govitekan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Drugs & drug classes ) - Treatment of patients with low-risk myelodysplastic syndrome
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2014, Spectrum ) - Venetoclax in the treatment of chronic lymphocytic leukemia
MUDr. Juliana Holasová, MUDr. Alexander Wild, PhD.
(3/2026, Original articles ) - SYSTEMIC TREATMENT FOR ADVANCED HEPATOCELLULAR CANCER
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(1/2008, Review articles ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Myelodysplastic syndrome – medicine made to measure
MUDr. Eva Mikušková, doc. MUDr. Ján Staško, PhD., MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(6/2014, Spectrum ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - Human microbiome and colorectal cancer
doc. MUDr. Michal Mego, PhD., doc. RNDr. Vladimír Zajac, CSc., RNDr. Soňa Čierniková, PhD., Viola Števurková, Mgr. Nikola Ďuríková, RNDr. Lenka Wachsmannová, PhD.
(5/2016, Review articles ) - A patient with metastatic colorectal adenocarcinoma treated with chemotherapy in combination with bevacizumab
MUDr. Michal Mego, PhD., MUDr. Zuzana Syčová-Milá, MUDr. Jana Obertová, MUDr. Patrik Palacka, PhD., MUDr. Ján Rajec, PhD., doc. MUDr. Jozef Mardiak, CSc., mim. prof.
(1/2011, Original articles & case reports ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - The genetic profile is determinating the choice of treatment of de-novo patients with chronic lymphocytic leukemia
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD., MUDr. Jozef Lukáš, PhD.
(2/2024, Review articles ) - Chronic lymphocytic leukemia - how to treat a patient with relapsed or refractory disease in the era of signaling pathway inhibitors
MUDr. Firas Farkaš, PhD.
(1/2022, Case reports ) - Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
MUDr. Eva Bojtárová, PhD.
(2/2024, Review articles ) - Brentuximab vedotin for the treatment of patients with Hodgkin lymphoma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. Anna Chbat, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD., Prof. MUDr. Ján Staško, PhD.
(1/2022, Drugs & drug classes ) - Innovative treatment of chronic lymphocytic leukemia using chemo-free strategies, ringing the bell for chemotherapy?
MUDr. Firas Farkaš, PhD.
(5/2021, Review articles ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial
doc. MUDr. Peter Beržinec, CSc.
(3/2006, Information & comments ) - Enfortumab vedotin in advanced urothelial carcinoma treatment
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(5/2021, Drugs & drug classes ) - Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
doc. MUDr. Martin Mistrík, PhD., doc. MUDr. Angelika Bátorová, PhD., MUDr. Ľubica Roziaková, PhD.
(3/2014, Review articles ) - Practical aspects of daratumumab therapy in the treatment of multiple myeloma
MUDr. Miriam Ladická
(5/2024, Review articles ) - Standard treatment of advanced urothelial carcinoma in first line
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(5/2024, Review articles ) - Antibody-drug conjugates (ADCs): a revolution in the treatment of metastatic breast cancer?
MUDr. Bibiána Vertáková Krakovská, PhD.
(4/2025, Main topic ) - Hodgkin lymphoma in combination with myasthenia gravis – case report
MUDr. Martin Sedmina, MUDr. Alexander Wild, PhD., Prof. MUDr. Eva Králíková, CSc., MUDr. Viera Štulajterová, MUDr. Erika Rauschová, MUDr. Silvia Borková, MUDr. Miriam Zválená, MUDr. Anna Ondrejčeková, MUDr. Juliana Holasová, MUDr. Anna Vallová, MUDr. Daniela Kubincová, MUDr. Margaréta Králiková, MUDr. Alžbeta Púčaťová, MUDr. Imrich Markuljak, MUDr. Erika Čellárová, MUDr. Martina Martiníková, PhD., MUDr. Viera Holecová, MUDr. Ján Kothaj
(5/2024, Case reports ) - Publikujeme v zahraničí
(3/2014, Information & comments ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Systemic treatment of local advanced non resekability or metastatic urothelial carcinoma
MUDr. Jana Obertová, PhD.
(2/2021, Review articles ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Bratislavské onkologické dni, LVIII. ročník – odborný program a abstrakty
Kolektív autorov
(S2/2021, Abstracts ) - Bratislavské onkologické dni, LVII. ročník – odborný program a abstrakty
Kolektív autorov
(S3/2020, Abstracts ) - NEW ANTIMICROBIAL SUBSTANCES AND THEIR IMPORTANCE FOR ONCOLOGY PATIENTS – OVERVIEW
h.doc. MUDr. Ľuboš Drgoňa, CSc.
(4/2006, Review articles ) - Primary treatment of metastatic prostate cancer
MUDr. Matej Hrnčár, MUDr. Marek Lafférs, MUDr. Jozef Breznický, MUDr. Ján Šulgan, MUDr. Juraj Sokol, PhD., PhD., MUDr. Juraj Chudej, PhD.
(5/2017, Review articles ) - Topotecan in the treatment of recurrent ovarian carcinoma – the retrospective analysis
doc. MUDr. Jozef Mardiak, CSc., MUDr. Jozef Šufliarsky, MUDr. Oliver Sadovský, CSc., MUDr. Tomáš Minarik, MUDr. Michaela Kubíčková, MUDr. Tibor Lengyel, MUDr. Bohuslav Nižňanský
(6/2009, Original articles & case reports ) - Cetuximab – a chimeric monoclonal IgG1 antibody for the treatment of patients with squamous cell cancer of the head and neck
doc. PharmDr. Juraj Sýkora, CSc.
(6/2009, Drugs & drug classes ) - The choriocarcinoma syndrome in men with germ cell tumors
MUDr. Katarína Rejleková, PhD.
(3/2019, Review articles ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - Possibility of applying probiotics in oncology
prof. MUDr. Ľudovít Danihel, PhD., doc. MUDr. Michal Mego, PhD., MUDr. Vladimír Holec, MUDr. Agáta Holecová, doc. RNDr. Vladimír Zajac, CSc., Mgr. Zuzana Adamčíková
(4/2011, Review articles ) - Publikujeme v zahraničí
Kolektív autorov
(4/2022, Information & comments ) - Febrile neutropenia – view on antimicrobial stewardship in oncohaematology
doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Andrej Vranovský, PhD., MUDr. Eva Mikušková, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Miriam Ladická
(5/2020, Review articles ) - Update of treatment options in myelodysplastic syndrome
MUDr. Veronika Markuseková, prof. MUDr. Angelika Bátorová, PhD., doc. MUDr. Peter Rohoň, PhD.
(6/2021, Review articles ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - A comprehensive view of the treatment of metastatic hormone sensitive prostate cancer
prof. MUDr. Ján Kliment, CSc., MUDr. Ing. Monika Kuzma, MBA
(5/2019, Main topic ) - Anti-EGFR treatment in colorectal cancer – what is ist role today and in the future?
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(5/2019, Review articles ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - DIAGNOSIS AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
h. doc. MUDr. Ľuboš Drgoňa, CSc.
(5/2008, Review articles ) - Follicular lymphoma: present and perspective in treatment
MUDr. Adriana Kafková, prof. MUDr. Elena Tóthová, CSc.
(3/2017, Spectrum ) - 5. konferencia Slovenskej spoločnosti radiačnej onkológie – odborný program a abstrakty
Kolektív autorov
(S2/2022, Abstracts ) - Antibody-drug conjugates in the treatment of breast cancer
MUDr. Miroslava Malejčíková
(4/2026, Main topic ) - The combination of cetuximab and radiotherapy in the first line treatment of colorectal carcinoma – The Slovak project
MUDr. Tomáš Šálek, MUDr. Marián Streško, MUDr. Jozef Chovanec, MUDr. Eduard Šebo, MUDr. Dagmar Mazalová, MUDr. Alena Thomková, a ďalší
(5/2010, Original articles & case reports ) - Bratislavské onkologické dni, LX. ročník – odborný program a abstrakty
Kolektív autorov
(S1/2023, Abstracts ) - Antibody-drug conjugates in the treatment of advanced gynaecological malignancies
MUDr. Róbert Biel, PhD., MBA
(4/2026, Main topic ) - Position of radiotherapy in the treatment of generalized prostate cancer
MUDr. Viktor Rosenberg, PhD.
(3/2017, Review articles ) - Ixazomib, lenalidomide, dexamethasone in the treatment of patients with relapsed and refractory multiple myeloma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. František Nehaj, MUDr. Lenka Lisá, PhD., MUDr. Matej Hrnčár, PhD., Prof. MUDr. Ján Staško, PhD.
(3/2020, Review articles ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - When antibodies treat: a new era in the treatment of multiple myeloma
MUDr. Miriam Ladická
(4/2026, Main topic ) - Treatment of relapsed and refractory myeloma
MUDr. Alexander Wild
(4/2013, Focus ) - Novinky v onkológii
MUDr. Tomáš Šálek
(1/2019, Information & comments ) - The case of a patient with acute mast cell leukaemia
MUDr. Tomáš Guman, PhD., MBA
(3/2024, Review articles ) - Publikujeme v zahraničí
Kolektív autorov
(3/2021, Information & comments ) - Efficacy of maintenance therapy with the PARP inhibitor olaparib in platinum-sensitive recurrent ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(3/2024, Case reports ) - Waldenström‘s macroglobulinemia and treatment
MUDr. Radoslav Greksák, PhD.
(1/2019, Review articles ) - Publikujeme v zahraničí
(4/2026, Information & comments ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Bratislavské onkologické dni 63. ročník 30. 9. – 2. 10. 2026, Bratislava
(S3/2026, Abstracts ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Bratislavské onkologické dni LIX. ročník
Kolektív autorov
(S4/2022, Abstracts ) - Bratislavské onkologické dni LVI. ročník
Kolektív autorov
(S3/2019, Abstracts ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - New EBMT’s recommendations for GvHD prophylaxis and treatment
MUDr. Firas Farkaš, PhD.
(2/2025, Review articles ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - Nilotinib – inhibítor tyrozínkinázy na liečbu chronickej myelocytovej leukémie (CML)
doc. PharmDr. Juraj Sýkora, CSc.
(2/2009, Drugs & drug classes ) - Pegylated liposomal doxorubicin in the treatment of recurent ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2009, Review articles ) - Current indications for pemetrexed in the treatment of non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Review articles ) - Publikujeme v zahraničí
Kolektív autorov
(2/2022, Information & comments ) - Lipegfilgrastim − new drug form similar to filgrastim in treatment of neutropenia of oncologic patients
prof. PharmDr. Ján Kyselovič, CSc., PharmDr. Andrea Gažová, PhD.
(4/2015, Drugs & drug classes ) - Neutropenic enterocolitis
MUDr. Barbora Kašperová, MUDr. Stela Kašperová
(5/2022, Review articles ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - Lenalidomide in the treatment of mantle cell lymphoma
Doc. MUDr. Ľuboš Drgoňa, CSc., MHA
(6/2017, Drugs & drug classes ) - 25 years of the Department of Clinical Trials of National Cancer Institute
RNDr. Daniela Svetlovská, PhD., Alžbeta Jančíková, Simona Turňová, Bc. Andrea Krieschová
(2/2020, Main topic ) - 9TH TH WORLD CONGRESS ON GASTROINTESTINAL CANCER, 27. – 30. JÚN 2008, BARCELONA
MUDr. Tomáš Šálek
(3/2008, Events ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Febrile neutropenia in oncology practice
MUDr. Zuzana Matulová, MUDr. Andrej Vranovský, PhD., doc. MUDr. Ľuboš Drgoňa, CSc., MHA, FECMM
(2/2026, Review articles ) - Bratislavské onkologické dni LXI. ročník- Odborný program a abstrakty
Kolektív autorov
(S3/2024, Abstracts ) - Chronic myeloid leukemia and its treatment in patients with repeated intolerance of tyrosine kinase inhibitors
MUDr. Radoslav Greksák, PhD.
(2/2020, Case reports ) - Publikujeme v zahraničí
(2/2013, Information & comments ) - Advances in the treatment of T-cell lymphomas
MUDr. Lucia Petríková, PhD., MUDr. Andrej Vranovský, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(6/2022, Main topic ) - Advances in the systemic treatment of non-small cell lung cancer
MUDr. Mária Černá, CSc.
(2/2023, Main topic ) - Acute hematologic emergencies in oncology
MUDr. Ľudmila Krištof
(1/2012, Review articles ) - Vinflunine in the metastatic urothelial carcinoma treatment after disease progression on gemcitabine with cisplatin – case-report
doc. MUDr. Jozef Mardiak, CSc., mim. prof., doc. MUDr. Michal Mego, PhD., MUDr. Štefánia Lišková, MUDr. Patrik Palacka, PhD., MPH, MBA, MUDr. Jana Obertová, PhD.
(5/2013, Original articles & case reports ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - ANTIBACTERIAL PROPHYLAXIS IN NEUTROPENIC CANCER PATIENTS
h. doc. MUDr. Ľuboš Drgoňa
(5/2007, Review articles ) - Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - GROWTH FACTORS IN ONCOLOGY (part 1)
prof. MUDr. Elena Tóthová, CSc.
(5/2007, Review articles ) - Febrile neutropenia
MUDr. Ľuboš Drgoňa, CSc.
(1/2012, Review articles ) - Long-term response and remission with pixantrone in 4th line treatment in patient with relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2020, Case reports ) - Practical experience with the treatment of elderly patients with acute myeloblastic leukaemia with the combination of azacitidine and venetoclax
MUDr. Jozef Lukáš, PhD., MUDr. Ladislav Sopko, PhD., MPH., MUDr. Balázs Gálffy, MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(4/2024, Case reports ) - How I manage febrile neutropenia
doc. MUDr. Ľuboš Drgoňa, CSc.
(5/2023, Main topic ) - Mantle cell lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2024, Main topic ) - Primary lymphomas of the central nervous system – results of treatment in Slovak centres
MUDr. Ján Sýkora, MUDr. Tomáš Guman, PhD., MBA, doc. MUDr. Ľuboš Drgoňa, CSc., MHA, FECMM, MUDr. Andrej Vranovský, PhD., MUDr. Marek Nemec, MUDr. Eva Králiková, MUDr. Radoslava Šimonová, PhD., MUDr. Juliana Gabzdilová, PhD., MUDr. Alexander Wild, PhD., doc. MUDr. Juraj Sokol, PhD.
(1/2024, Main topic ) - Infectious complications in the treatment of oncohematological patients – can they be prevented?
MUDr. Iveta Oravcová, PhD.
(5/2023, Review articles ) - Treatment of diffuse large cell non-Hodgkin›s lymphoma in the geriatric population – are we doing things differently?
MUDr. Jana Tabišová
(1/2024, Main topic ) - Drug profile – loncastuximab tesirine
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Richard Jusko, MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, MUDr. Lenka Lisá, PhD., MUDr. Ivana Plameňová, PhD., MBA
(6/2025, Main topic ) - v
prof. MUDr. Dalibor Ondruš, DrSc., MUDr. Vanda Ušáková, PhD.
(6/2012, Main topic ) - Early invasive pulmonary aspergillosis with fatal outcome in a patient with acute lymphoblastic leukemia
doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Miroslav Gašpar, RNDr. Miroslava Pőczová, PhD., RNDr. Martina Sládeková
(2/2015, Original articles & case reports ) - Four year continuation of treatment response in a patient with advanced myeloma–a case report
MUDr. Zdenka Štefániková, doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(S3/2018, Original works & case studies ) - Long-term control of a resistant/relapsing myeloma by combinated immunochemotherapy – case report
MUDr. Natália Štecová
(S3/2018, Original works & case studies ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - COVID-19 and breast cancer
MUDr. Bela Mriňáková, PhD., MPH, Sára Gočárová, MUDr. Klaudia Gočárová, PhD.
(3/2022, Main topic ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - Treatment of germinal tumor during the COVID-19 pandemic
MUDr. Miriam Hančinová, MUDr. Peter Zuzák, prof. MUDr. Dalibor Ondruš, DrSc., MUDr. Bela Mriňáková, PhD., MPH
(3/2022, Main topic ) - Čo možno očakávať od súčasnej liečby mKRK v 3. a 4. línii?
Doc. MUDr. Igor Kiss, Ph.D.
(S5/2018, Supplement ) - Immunotherapy for muscle infiltrating urothelial carcinoma in 2025
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(3/2025, Main topic ) - Voľba fotemustínu v prípade cytostatickej liečby metastatického melanómu – kazuistika
MUDr. Róbert Godál
(S5/2018, Supplement ) - Imunotherapy of malignant lymphomas in senility
MUDr. Štefan Raffáč, PhD., MPH, MUDr. Juliana Gabzdilová, PhD., MBA, Doc. MUDr. Viola Vargová, PhD., MUDr. Atila David Homolya, MUDr. Filip Breznen, MUC. Martina Mária Raffáčová
(3/2025, Main topic ) - Treatment of BRAF wt metastatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(4/2021, Review articles ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - 4. konferencia Slovenskej spoločnosti radiačnej onkológie 26. – 27. apríl 2018, Ružomberok
Kolektív autorov
(S2/2018, Supplement ) - Bratislavské onkologické dni LV. ročník
Kolektív autorov
(S4/2018, Supplement ) - Current options for the use of PARP inhibitors in patients with metastatic castration-resistant prostate cancer with impaired DNA repair mechanisms
MUDr. Radovan Barila, PhD.
(3/2025, Review articles ) - Systemic invasive mucormycosis as a cause of early death of a child with acute myelogenous leukemia
MUDr. Alexandra Kolenová, PhD., MUDr. Branislav Chrenka, MUDr. Martin Fula, MUDr. Adriána Podhorská, MUDr. Peter Martanovič, MUDr. Lucia Kolenová, MUDr. Dana Petržalková
(2/2014, Original articles & case reports ) - A new era in the treatment of chronic lymphocytic leukemia: venetoclax as a tool for modern therapy – a retrospective group from Slovakia
MUDr. Firas Farkaš, PhD., Prof. MUDr. Mikuláš Hrubiško, CSc., MUDr. Zdenka Štefániková, MUDr. Zuzana Sninská, PhD., MUDr. Eva Luptáková, MUDr. Jana Juranová, MUDr. Ladislav Fekete, MUDr. Enikő Radi, MUDr. Eva Dingová, prof. MUDr. Angelika Bátorová, PhD.
(3/2025, Original articles ) - Colony stimulating factors in oncology
MUDr. Ivan Dekánek
(4/2017, Review articles ) - The benefit of lenalidomide in the treatment of patients with newly diagnosed multiple myeloma
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Richard Jusko, MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, MUDr. Lenka Lisá, PhD., MUDr. Ivana Plameňová, PhD., MBA
(1/2025, Drugs & drug classes ) - New possibilities in the 3rd and 4th line of treatment of metastatic colorectal cancer
MUDr. Tomáš Šálek
(4/2017, Drugs & drug classes ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Chemotherapy for malignant pleural mesothelioma
doc. MUDr. Peter Beržinec, CSc.
(6/2011, Review articles ) - Niektoré nové poznatky zo sympózia ASCO GI San Francisco 2018
MUDr. Tomáš Šálek
(1/2018, Events ) - CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3/2007, Review articles - treatment ) - Odborný program a abstrakty, 7. konferencia Slovenskej spoločnosti radiačnej onkológie 21. – 22. máj 2026, Trencín
Kolektív autorov
(S2/2026, Abstracts ) - Nanoliposomal irinotecan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(1/2021, Drugs & drug classes ) - Systemic treatment of advanced pancreatic cancer and the role of nanoliposomal irinotecan in it
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Main topic ) - When prophylaxis fails: invasive fungal diseases in leukemia in clinical practice
MUDr. Denis Urban, MUDr. Eva Mikušková, PhD., MBA, prof. RNDr. Vanda Repiská, PhD., MPH, MUDr. Martin Rázus, doc. MUDr. Ľuboš Drgoňa, CSc., MHA, FECMM
(3/2026, Review articles )
- CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3-4/2007, clearly ) - Intravenous immunoglobulin therapy for neurologic disorders: an update and practical issues
doc. MUDr. Peter Špalek, CSc.
(1/2009, Review articles )
- Paliatívna medicína a liečba bolesti - suplement 2010/S3
Kolektív autorov
(S3/2010, Content )
- Nové liečivá v EÚ registrované v roku 2014 (IV.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3-4/2015, New drugs ) - New option for the treatment of neutropenia − lipegfilgrastim
Mgr. Ivana Pankuchová
(1/2015, Drug profile ) - New intravenous cephalosporines in pediatrics: ceftaroline, and ceftazidime-avibactam
doc. MUDr. Ľubica Kováčiková, PhD.
(4/2022, Current pharmacotherapy )
- First reported case of Pearson syndrome in Slovakia with atypical phenotype of short stature and mesomelia
RNDr. Gabriela Bľandová, PhD., MUDr. Michaela Murgašová, MUDr. Adam Markocsy, PhD., Mgr. Marian Baldovič, PhD., Mgr. Gabriela Krasňanská, Mgr. Vladimír Eliaš, prof. RNDr. Vanda Repiská, PhD., RNDr. Michal Konečný, PhD.
(1/2026, Original articles & case reports )